Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort

Arthritis Care and Research

Volumn 68, Issue 10, 2016, Pages 1554-1559

  Baer, Alan N ^a   Medrano, Leah ^a   McAdams DeMarco, Mara ^b   Gniadek, Thomas J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; LA ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BLOOD PROTEIN DISORDER; CONTROLLED STUDY; DILATED CAPILLARY LOOP; DISEASE ASSOCIATION; DISEASE SEVERITY; EXOCRINE GLANDULAR DYSFUNCTION; FEMALE; FIBROSIS; HUMAN; HYPERGLOBULINEMIA; LABIAL GLAND FIBROSIS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; ORAL MUCOSAL TELANGIECTASIA; PHENOTYPE; PHYSICAL DISEASE BY ANATOMICAL STRUCTURE; RACE DIFFERENCE; RAYNAUD PHENOMENON; RISK; SALIVATION; SCHIRMER TEST; SCLERODACTYLY; SEX DIFFERENCE; SIALOADENITIS; SJOEGREN SYNDROME; SKIN DISEASE; SYSTEMIC SCLEROSIS; TELANGIECTASIA; UNSTIMULATED WHOLE SALIVA FLOW RATE;

EID: 84988925746     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22859     Document Type: Article

References (16)

1. Collins K, Mitchell S, Griffiths B, Bowman SJ, Ng WF, United Kingdom Primary Sjögren's Syndrome Registry. Potential diagnostic utility of anti-centromere antibody in primary Sjögren's syndrome in the UK [letter]. Clin Rheumatol 2012;31:1147–8.
2. Bournia VK, Diamanti KD, Vlachoyiannopoulos PG, Moutsopoulos HM. Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis. Arthritis Res Ther 2010;12:R47.
3. Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome. J Rheumatol 2007;34:2253–8.
4. Baldini C, Mosca M, Della Rossa A, Pepe P, Notarstefano C, Ferro F, et al. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheumatol 2013;31:272–80.
5. Nakamura H, Kawakami A, Hayashi T, Iwamoto N, Okada A, Tamai M, et al. Anti-centromere antibody-seropositive Sjögren's syndrome differs from conventional subgroup in clinical and pathological study. BMC Musculoskelet Disord 2010;11:140.
6. Katano K, Kawano M, Koni I, Sugai S, Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. J Rheumatol 2001;28:2238–44.
7. Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H, et al, for the Sjögren's International Collaborative Clinical Alliance Research Groups. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum 2011;63:2021–30.
8. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012;64:475–87.
9. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis, Nat Methods 2012;9:676–82.
10. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737–47.
11. Mahler M, You D, Baron M, Taillefer SS, Hudson M, and the Canadian Scleroderma Research Group (CSRG), et al. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA. Clin Chim Acta 2011;412:1937–43.
12. Fritzler MJ, Rattner JB, Luft LM, Edworthy SM, Casiano CA, Peebles C, et al. Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Autoimmun Rev 2011;10:194–200.
13. Gelber AC, Pillemer SR, Baum BJ, Wigley FM, Hummers LK, Morris S, et al. Distinct recognition of antibodies to centromere proteins in primary Sjögren's syndrome compared with limited scleroderma. Ann Rheum Dis 2006;65:1028–32.
14. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.
15. Kitagawa T, Shibasaki K, Toya S. Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjögren's syndrome. Clin Rheumatol 2012;31:105–12.
16. Osial TA Jr, Whiteside TL, Buckingham RB, Singh G, Barnes EL, Pierce JM, et al. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum 1983;26:500–8.